News
We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take ...
A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...
Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug, marketed and sold as Zepbound / Mounjaro. Hims & Hers ...
The drugmaker accuses Premier Weight Loss of risking patients' health by selling altered, unsterile versions of its ...
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as generics of Novo Nordisk's diabetes drug liraglutide through its weight loss ...
Eli Lilly is grabbing headlines thanks to medicines like Mounjaro for diabetes and Zepbound for weight management. What should investors do when stocks are tanking over the short term? Three ...
The active pharmaceutical ingredient (API) in Mounjaro, the weight-loss drug produced by Eli Lilly, is Ireland’s biggest pharmaceutical export to the US, and would be the hardest hit if US ...
Eli Lilly is grabbing headlines thanks to medicines like Mounjaro for diabetes and Zepbound for weight management. However, these therapies will run out of patent protection and stop being growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results